Novelix Pharmaceuticals Limited (BOM:536565)

Novelix Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Novelix Pharmaceuticals had annual revenue of 1.32B INR with 330.60% growth. Novelix Pharmaceuticals had revenue of 251.94M in the quarter ending March 31, 2026, with 20.78% growth.

• Revenue: 1.32B
• Revenue Growth: +330.60%
• P/S Ratio: 0.79
• Revenue / Employee: 165.42M
• Employees: 8
• Market Cap: 1.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.32B	1.02B	330.60%
Mar 31, 2025	307.33M	262.02M	578.26%
Mar 31, 2024	45.31M	26.11M	135.96%
Mar 31, 2023	19.20M	-69.92M	-78.45%
Mar 31, 2022	89.13M	-6.72M	-7.01%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error